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Adjusting for delay from confirmation to death, we 
estimated case and infection fatality ratios (CFR, IFR) 
for coronavirus disease (COVID-19) on the Diamond 
Princess ship as 2.6% (95% confidence interval (CI): 
0.89–6.7) and 1.3% (95% CI: 0.38–3.6), respectively. 
Comparing deaths on board with expected deaths 
based on naive CFR estimates from China, we esti-
mated CFR and IFR in China to be 1.2% (95% CI: 0.3–
2.7) and 0.6% (95% CI: 0.2–1.3), respectively.
In real time, estimates of the case fatality ratio (CFR) 
and infection fatality ratio (IFR) can be biased upwards 
by under-reporting of cases and downwards by failure 
to account for the delay from confirmation to death. 
Collecting detailed epidemiological information from 
a closed population such as the quarantined Diamond 
Princess cruise ship in Japan can produce a more com-
prehensive description of asymptomatic and sympto-
matic cases and their subsequent outcomes. Our aim 
was to estimate the IFR and CFR of coronavirus disease 
(COVID-19) in China, using data from passengers of the 
Diamond Princess while correcting for delays between 
confirmation and death and for the age structure of the 
population.
Situation on the cruise ship
On 1 February 2020, a patient tested positive for 
COVID-19 in Hong Kong; they had disembarked from 
the Diamond Princess cruise ship on 25 January [1,2]. 
This patient had had onset of symptoms on 19 January, 
one day before boarding the ship [1]. After its return 
to Yokohama, Japan, on 3 February, the ship was held 
in quarantine, during which testing was performed in 
order to measure COVID-19 infections among the 3,711 
passengers and crew members on board.
Passengers of the Diamond Princess were initially to 
be held in quarantine for 14 days until 17 February. 
However, those who had intense exposure to the con-
firmed case-patient, such as sharing a cabin, were held 
in quarantine beyond the initial 14-day window [2]. 
According to reference [2], by 20 February, there were 
619 confirmed cases on-board (17%), 318 of them were 
asymptomatic (asymptomatic cases were either self-
assessed to be symptomless or tested positive before 
symptom onset) and 301 were symptomatic [2]. Overall 
3,063 PCR tests were performed among passengers 
and crew members. Testing started among the elderly 
passengers, descending by age [2]. For details on the 
testing procedure, see [1] and [2].
Adjusting for outcome delay in case fatality 
ratio estimates
To date, there have been many estimates of the CFR 
of COVID-19, far too many to exhaustively summarise 
here. However, to give an idea, estimates range from 
0.4% (95% confidence interval (CI): 0.4–0.5) [3] to 
3.8% [4]. During an outbreak, the so-called naive CFR 
(nCFR), i.e. the ratio of reported deaths date to reported 
cases to date, will underestimate the true CFR because 
the outcome (recovery or death) is not known for all 
cases [5,6], assuming all cases are detected. We can 
estimate the true denominator for the CFR (i.e. the num-
ber of cases with known outcomes) by accounting for 
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Figure 
The time-to-death distributions and case and death data used to calculate the corrected case fatality estimates, Diamond 
Princess cruise ship, February 2020 (n = 3,711)
A. Delay distribution of hospitalisation to death in Wuhan, China
Date in 2020
B. Case time series of passengers on board the Diamond Princess (n = 705)
Date in 2020
C. Death time series of passengers on board the Diamond Princess (n = 7)
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Panel A represents a lognormal distribution fitted and reported in Linton et al. [7] (Table 2) using data from the outbreak in Wuhan, China. The 
distribution has a mean of 13 days and standard deviation of 12.7 days. Case and death time-series data is as reported until 5 March 2020 
and is taken from [8]. Nine negative cases on 5 March were removed from the figure for aesthetic purposes. However, they were included in 
the analysis.
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the delay from confirmation to death [6]. We assumed 
that the delay from confirmation to death followed the 
same distribution as the estimated time from hospitali-
sation to death, based on data from the COVID-19 out-
break in Wuhan, China, between 17 December 2019 and 
22 January 2020, accounting for underestimation in the 
data as a result of as-yet-unknown disease outcomes 
(Figure, panels A and B) [7]. As a sensitivity analysis, 
we also considered raw ‘non-truncated’ distributions, 
which do not account for censoring (i.e. because of the 
continued growth of the outbreak, cases with shorter 
incubation periods are more likely to be included in 
the data set); the raw and truncated distributions 
(Supplementary Figure S1) had a mean of 8.6 days and 
13 days, respectively (Supplementary Tables S1 and 
S2). 
Data sources
We used data from two different sources in our analy-
ses. Time-series for the date of confirmation of cases 
and the date of each death were taken from the World 
Health Organization situation reports [8], using data 
up to 5 March. The breakdown of which cases were 
symptomatic and which were asymptomatic was taken 
from [1] and [2], which included data up to 20 February. 
There were 634 cases in total by 20 February accord-
ing to [8] and 696 by 5 March. The asymptomatic vs 
symptomatic breakdown was taken from a total of 
619 cases [1]. For comparison, we ran an uncorrected 
version of the analysis using data up to 25 March in 
the Supplementary Material. Nine negative cases were 
officially reported on 5 March [8], which we included 
in our analysis but omitted from Figure 1 for aesthetic 
purposes.
To adjust the CFR to account for delay to outcome, we 
use the method developed in [6] where case and death 
incidence data are used to estimate the number of 
cases with known outcomes, i.e. cases where the reso-
lution, death or recovery, is known to have occurred:
where  ct  is the daily case incidence at time  t, (with 
time measured in calendar days),  ft  is the proportion 
of cases with delay t between onset or hospitalisation 
and death;  ut  represents the underestimation of the 
known outcomes [6,7] and is used to scale the value 
of the cumulative number of cases in the denominator 
in the calculation of the cCFR. Given that asymptomatic 
infections are typically not reported, especially during 
an ongoing outbreak of a novel infection, this correc-
tion is normally used to calculate the cCFR. However, 
because of the high level of testing on the cruise ship, 
we were able to use this correction to calculate the 
corrected IFR (cIFR). After that, we used the measured 
proportions of asymptomatic to symptomatic cases on 
the Diamond Princess to scale the cIFR to estimate the 
cCFR. Method and data are available at: https://github.
com/thimotei/cCFRDiamondPrincess.
Corrected infection fatality ratio and case 
fatality ratio estimates
We estimated that the all-age cIFR on the Diamond 
Princess was 1.3% (95% confidence interval (CI): 
0.38–3.6) and the cCFR was 2.6% (95% CI: 0.89–6.7) 
(Table 1). However, as the age distribution on the ship 
was skewed towards older individuals (mean age: 58 
years), we also report age-stratified estimates. Using 
the age distribution of cases and deaths on the ship 
[1,2] to estimate for only individuals 70 years and older, 
the cIFR was 6.4% (95% CI: 2.6–13) and the cCFR was 
13% (95% CI: 5.2–26) (Table 1). The 95% CI were cal-
culated with an exact binomial test, with death count 
and either cases or known outcomes (depending on 
whether it was an interval for the naive or corrected 
estimate).
Using an approach similar to indirect standardisation 
[9], we used the age-stratified nCFR estimates reported 
in a large study in China [10] to calculate the expected 
number of deaths of people on board the ship in each 
age group, (assuming this nCFR estimate in the stand-
ard population was accurate). This produced a total of 
15.15 expected deaths, which corresponds to a nCFR 
estimate of 5% (15.15/301) for the Diamond Princess 
(Table 2), which falls within the top end of our 95% 
CI. As our cCFR for Diamond Princess was 2.6% (95% 
CI: 0.89–6.7), this suggests we need to multiply the 
nCFR estimates in China [7] by a factor 52% (95% CI: 
14–100) to obtain the correct value. As the raw overall 
nCFR reported in the data from China was 2.3% [10], 
this suggests the cCFR in China during that period was 
1.2% (95% CI: 0.3–3.1) and the IFR was 0.6% (95% 
CI: 0.2–1.7). Based on cases and deaths reported in 
China up to 4 March 2020, the nCFR calculation was 
considerably higher than the cCFR we estimate here 
(based on data taken from [8], nCFR = 2,984/80,422 = 
3.71% (95% CI: 3.58–3.84)). The confidence intervals 
calculated for China using an indirect standardisation 
method reflect the uncertainty in the Diamond Princess 
estimates, as it is carried forward in the scaling.
Table 1
Corrected infection fatality ratio and corrected case 
fatality ratio estimates calculated from reported case and 
death data, Diamond Princess cruise ship, February 2020 
(n = 696)
Age group cIFR (95% CI) cCFR (95% CI)
All ages combined 1.3% (0.38–3.6) 2.6% (0.89–6.7)
≥ 70 years 6.4% (2.6–13) 13% (5.2–26)
CI: confidence interval; cCFR: corrected case fatality ratio; cIFR: 
corrected infection fatality ratio.
Data source: [8]. Correction was performed using Formula (1) and 
the hospitalisation-to-death distribution in [9].
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Discussion
As at 24 March 2020, there have been 386,317 con-
firmed cases of coronavirus disease 2019 (COVID-19), 
with 16,713 deaths [8]. It is challenging to accurately 
estimate the CFR in real time [5,11], especially for an 
infection with attributes similar to COVID-19, which 
has a delay of almost 2 weeks between confirmation 
and death, strong effects of age and comorbidities on 
mortality risk, and likely under-reporting of cases in 
many settings [10]. Using an age-stratified adjustment 
method, we accounted for changes in known outcomes 
over time. By applying this method to data from the 
Diamond Princess, we focused on a setting that was 
likely to have lower reporting error because large num-
bers were tested and the test had high sensitivity.
As the mean age on board the ship was 58 years, our 
cCFR estimates cannot directly be applied to a younger 
population; we therefore scaled our estimates to 
obtain values for a population with an age distribution 
equivalent to that in the outbreak in China. Although 
the Diamond Princess cohort was older, meaning that 
some deaths could be attributable to other causes, 
the natural death rate would have been much slower 
than the fatalities attributable to COVID-19. Given the 
limited background effect – and to ensure consistency 
with standard estimates of CFR rather than a hybrid 
‘burden over natural rate’ calculation – we assumed 
that all deaths among COVID-19 cases were the result 
of COVID-19.
Our analysis had additional limitations. Cruise ship 
passengers may have a different health status to the 
general population of their home countries, owing to 
health requirements to embark on a multi-week holi-
day, or differences related to socioeconomic status or 
comborbities. Deaths only occurred in individuals 70 
years or older, so we were not able to generate age-spe-
cific cCFRs; the fatality risk may also have been influ-
enced by differences in healthcare between countries. 
Because of likely age-specific differences in reporting, 
we focused on overall cCFR in China, rather than calcu-
lating age-specific cCFRs [10,11]. In doing so, we were 
assuming that there were no age-specific differences 
in under-reporting. The main source of potential bias 
in this assumption is the age-specific severity level of 
COVID-19; there may be far lower levels of detection 
in children if their symptoms are milder, meaning that 
they are tested less often.
Conclusion
Our analysis shows the importance of adjusting for 
delays from confirmation to outcome in real-time esti-
mates of fatality risk, and the benefits of combining 
datasets alongside appropriate age adjustments to 
provide early insights into COVID-19 severity.
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